{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:35:17Z","timestamp":1768685717320,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12094-017-1633-2","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T10:46:53Z","timestamp":1488365213000},"page":"1010-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines"],"prefix":"10.1007","volume":"19","author":[{"given":"M.","family":"Cuadros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1501-6681","authenticated-orcid":false,"given":"V.","family":"S\u00e1nchez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bali\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mart\u00edn-Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Boyero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Peinado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"1633_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","volume":"11","author":"BG Wilson","year":"2011","unstructured":"Wilson BG, Roberts CWM. SWI\/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11:481\u201392.","journal-title":"Nat Rev Cancer"},{"key":"1633_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000064638","volume":"69","author":"K Sentani","year":"2001","unstructured":"Sentani K, Oue N, Kondo H, Kuraoka K, Motoshita J, Ito R, et al. Increased expression but not genetic alteration of BRG1, a component of the SWI\/SNF complex, is associated with the advanced stage of human gastric carcinomas. Pathobiology. 2001;69:315\u201320.","journal-title":"Pathobiology"},{"key":"1633_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/pros.20521","volume":"67","author":"Sun Al","year":"2007","unstructured":"Al Sun, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, et al. Aberrant expression of SWI\/SNF catalytic subunits BRG1\/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate. 2007;67:203\u201313.","journal-title":"Prostate"},{"key":"1633_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1365-2133.2010.09851.x","volume":"163","author":"Hl Lin","year":"2010","unstructured":"Lin Hl, Wong RP, Martinka M, Li G. BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol. 2010;163:502\u201310.","journal-title":"Br J Dermatol"},{"key":"1633_CR5","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1541-7786.MCR-13-0427","volume":"12","author":"S Song","year":"2014","unstructured":"Song S, Walter V, Karaca M, Li Y, Bartlett CS, Smiraglia DJ, et al. Gene silencing associated with SWI\/SNF complex loss during NSCLC development. Mol Cancer Res. 2014;12:560\u201370.","journal-title":"Mol Cancer Res"},{"key":"1633_CR6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2013-02-483495","volume":"123","author":"Manuel Buscarlet","year":"2014","unstructured":"Buscarlet Manuel, Krasteva Veneta, Ho Lena, Simon Camille, H\u00e9bert Jos\u00e9e, Wilhelm Brian, et al. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood. 2014;123:1720\u20138.","journal-title":"Blood"},{"key":"1633_CR7","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1101\/gad.232710.113","volume":"27","author":"J Shi","year":"2013","unstructured":"Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe J, et al. Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated MYC regulation. Genes Dev. 2013;27:2648\u201362.","journal-title":"Genes Dev"},{"key":"1633_CR8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/jnci\/djn416","volume":"100","author":"N Pottier","year":"2008","unstructured":"Pottier N, Yang W, Assem M, Panetta JC, Pei D, Paugh SW, et al. The SWI\/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst. 2008;100:1792\u2013803.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl","key":"1633_CR9","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/ng1798","volume":"38","author":"N Rajewsky","year":"2006","unstructured":"Rajewsky N. microRNA target predictions in animals. Nat Genet. 2006;38(Suppl):S8\u201313.","journal-title":"Nat Genet"},{"key":"1633_CR10","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/sj.leu.2405031","volume":"22","author":"S Takada","year":"2008","unstructured":"Takada S, Yamashita Y, Berezikov E, Hatanaka H, Fujiwara S, Kurashina K, et al. MicroRNA expression profiles of human leukemias. Leukemia. 2008;22:1274\u20138.","journal-title":"Leukemia"},{"key":"1633_CR11","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1182\/blood-2010-09-308064","volume":"117","author":"I Dunand-Sauthier","year":"2011","unstructured":"Dunand-Sauthier I, Santiago-Raber ML, Capponi L, Vejnar CE, Schaad O, Irla M, et al. Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood. 2011;117:4490\u2013500.","journal-title":"Blood"},{"key":"1633_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic\/microRNA-155 for normal immune function. Science. 2007;316:608\u201311.","journal-title":"Science"},{"key":"1633_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.1141229","volume":"316","author":"TH Thai","year":"2007","unstructured":"Thai TH, Calado DP, Casola S, Ansel KM, Xiao C. Xue Yet al. Regulation of the germinal center response by microRNA-155. Science. 2007;316:604\u20138.","journal-title":"Science"},{"key":"1633_CR14","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA. 2005;102:3627\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1633_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/path.1825","volume":"207","author":"J Kluiver","year":"2005","unstructured":"Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol. 2005;207:243\u20139.","journal-title":"J Pathol."},{"key":"1633_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45:592\u2013601.","journal-title":"Nat Genet"},{"key":"1633_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2159-8290.CD-13-0799","volume":"4","author":"OA Romero","year":"2014","unstructured":"Romero OA, Torres-Diz M, Pros E, Savola S, Gomez A, Moran S, et al. MAX inactivation in small cell lung cancer disrupts MYC-SWI\/SNF programs and is synthetic lethal with BRG1. Cancer Discov. 2014;4:292\u2013303.","journal-title":"Cancer Discov."},{"issue":"5","key":"1633_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/humu.20730","volume":"29","author":"PP Medina","year":"2008","unstructured":"Medina PP, Romero OA, Kohno T, Montuenga LM, Pio R, Yokota J, Sanchez-Cespedes M. Frequent BRG1\/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat. 2008;29(5):617\u201322. doi:\n                    10.1002\/humu.20730\n                    \n                  .","journal-title":"Hum Mutat"},{"issue":"2","key":"1633_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4161\/epi.3.2.6153","volume":"3","author":"PP Medina","year":"2008","unstructured":"Medina PP, Sanchez-Cespedes M. Involvement of the chromatin-remodeling factor BRG1\/SMARCA4 in human cancer. Epigenetics. 2008;3(2):64\u20138.","journal-title":"Epigenetics"},{"issue":"7","key":"1633_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/hmg\/ddi091","volume":"14","author":"PP Medina","year":"2005","unstructured":"Medina PP, Carretero J, Ballestar E, Angulo B, Lopez-Rios F, Esteller M, Sanchez-Cespedes M. Transcriptional targets of the chromatin-remodelling factor SMARCA4\/BRG1 in lung cancer cells. Hum Mol Genet. 2005;14(7):973\u201382.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1633_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/gcc.20068","volume":"41","author":"PP Medina","year":"2004","unstructured":"Medina PP, Carretero J, Fraga MF, Esteller M, Sidransky D, Sanchez-Cespedes M. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4\/BRG1, in lung tumors. Genes Chromosomes Cancer. 2004;41(2):170\u20137.","journal-title":"Genes Chromosomes Cancer"},{"key":"1633_CR22","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1158\/0008-5472.CAN-14-3798","volume":"75","author":"B Vangamudi","year":"2015","unstructured":"Vangamudi B, Paul TA, Shah PK, Kost-Alimova M, Nottebaum L, Shi X, et al. The SMARCA2\/4 ATPase domain surpasses the bromodomain as a drug target in SWI\/SNF-mutant cancers: insights from cDNA rescue and PFI-3 inhibitor studies. Cancer Res. 2015;75:3865\u201378.","journal-title":"Cancer Res"},{"key":"1633_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13045-014-0081-5","volume":"7","author":"S Schiaffino-Ortega","year":"2014","unstructured":"Schiaffino-Ortega S, Balinas C, Cuadros M, Medina PP. SWI\/SNF proteins as targets in cancer therapy. J Hematol Oncol. 2014;7:81.","journal-title":"J Hematol Oncol"},{"key":"1633_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/hmg\/ddu554","volume":"24","author":"IF Coira","year":"2015","unstructured":"Coira IF, Rufino-Palomares EE, Romero OA, Peinado P, Metheetrairut C, Boyero-Corral L, et al. Expression inactivation of SMARCA4by microRNAs in lung tumors. Hum Mol Genet. 2015;24:1400\u20139.","journal-title":"Hum Mol Genet"},{"key":"1633_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.leukres.2015.04.017","volume":"39","author":"D Salemi","year":"2015","unstructured":"Salemi D, Cammarata G, Agueli C, Augugliaro L, Corrado C, Bica MG, et al. miR-155 regulative network in FLT3 mutated acute myeloid leukemia. Leuk Res. 2015;39:883\u201396.","journal-title":"Leuk Res"},{"key":"1633_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/imm.12227","volume":"142","author":"N Ruffin","year":"2014","unstructured":"Ruffin N, L\u00e9vy Y, Swaminathan S. Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology. 2014;142:32\u20138.","journal-title":"Immunology"},{"key":"1633_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/leu.2011.151","volume":"26","author":"ML Den Boer","year":"2012","unstructured":"Den Boer ML. MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia. 2012;26:1\u201312.","journal-title":"Leukemia"},{"key":"1633_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/leu.2014.231","volume":"3","author":"D Gerloff","year":"2015","unstructured":"Gerloff D, Grundler R, Wurm AA, Br\u00e4uer-Hartmann D, Katzerke C, Hartmann JU, et al. NF-\u03baB\/STAT5\/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia. 2015;3:535\u201347.","journal-title":"Leukemia"},{"key":"1633_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/path.2333","volume":"215","author":"M Wang","year":"2008","unstructured":"Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, et al. miRNA analysis in B cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC\/miR-155 expression. J Pathol. 2008;215:13\u201320.","journal-title":"J Pathol"}],"updated-by":[{"DOI":"10.1007\/s12094-019-02186-9","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T00:00:00Z","timestamp":1564185600000},"record-id":"21954"},{"DOI":"10.1007\/s12094-019-02178-9","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"record-id":"20951"},{"DOI":"10.1007\/s12094-019-02186-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000}}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-017-1633-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1633-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1633-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T22:48:02Z","timestamp":1600296482000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-017-1633-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1007\/s12094-017-1633-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12094-019-02186-9","asserted-by":"object"}]},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"assertion":[{"value":"14 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Upon publication, it came to our attention that certain revisions were necessary to honor the agreement between University of Hawaii and APEC Climate Center for the project, \ufffd\ufffd\ufffdDevelopment of APCC Seamless Prediction System\ufffd\ufffd\ufffd. There are three sections that are to be corrected to accurately reflect the agreement of project.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Upon publication, it came to our attention that certain revisions were necessary to honor the agreement between University of Hawaii and APEC Climate Center for the project, \ufffd\ufffd\ufffdDevelopment of APCC Seamless Prediction System\ufffd\ufffd\ufffd. There are three sections that are to be corrected to accurately reflect the agreement of project.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest. All data are true and accurate to the knowledge of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. Therefore, informed consent is not included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"PM\u2019s lab is funded by the Ministry of Economy of Spain (SAF2015-67919-R), Junta de Andaluc\u00eda (P12-BIO-1655), the Deutsche Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung, BBVA Foundation, and Eduardo-Gallego Grant 2015 from Francisco Cobos Foundation and J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}